Rhythm Pharmaceuticals Inc (RYTM)
NASDAQ:RYTM
Holding RYTM?
Track your performance easily

Rhythm Pharmaceuticals (RYTM) Financial Statements

435 Followers

Rhythm Pharmaceuticals Financial Overview

Rhythm Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-4.366; its P/E ratio is -11.12; Rhythm Pharmaceuticals is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $-0.81. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 29.08M$ 25.97M$ 24.23M$ 22.50M$ 19.22M
Gross Profit$ 26.13M$ 23.16M$ 21.00M$ 20.09M$ 16.98M
EBIT$ -27.18M$ -136.32M-$ -40.65M$ -43.40M
EBITDA$ -26.79M$ -133.96M-$ -37.06M$ -39.83M
Net Income Common Stockholders$ -33.56M$ -141.37M$ -41.63M$ -44.16M$ -46.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 319.13M$ 201.20M$ 275.85M$ 299.26M$ 253.60M
Total Assets$ 381.85M$ 258.65M$ 332.75M$ 354.20M$ 309.94M
Total Debt$ 4.12M$ 1.08M$ 1.26M$ 1.44M$ 1.61M
Net Debt$ -315.01M$ -200.12M$ -274.59M$ -297.82M$ -251.99M
Total Liabilities$ 342.50M$ 197.07M$ 162.99M$ 156.72M$ 127.66M
Stockholders Equity$ 39.34M$ 61.58M$ 169.76M$ 197.47M$ 182.28M
Cash Flow-
Free Cash Flow$ -29.08M$ -80.74M-$ -29.52M$ -41.97M
Operating Cash Flow$ -29.08M$ -40.74M$ -29.38M$ -29.25M$ -41.09M
Investing Cash Flow$ -8.56M$ 30.05M$ 22.64M$ -94.96M$ 48.19M
Financing Cash Flow$ 146.18M$ 4.24M$ 2.42M$ 73.04M$ -965.00K
Currency in USD

Rhythm Pharmaceuticals Earnings and Revenue History

Rhythm Pharmaceuticals Debt to Assets

Rhythm Pharmaceuticals Cash Flow

Rhythm Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis